Question

In: Accounting

Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended...

Forecast the Balance Sheet

Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016.

Medtronic plc
Consolidated Balance Sheets
($ millions) Apr. 29, 2016 Apr. 24, 2015
Current assets
Cash and cash equivalents $2,768 $4,843
Investments 9,758 14,637
Accounts receivable 5,562 5,112
Inventories 3,473 3,463
Tax assets 697 1,335
Prepaid expenses and other current assets 1,234 1,454
Total current assets 23,492 30,844
Property, plant, and equipment, net 4,841 4,699
Goodwill 41,500 40,530
Other intangible assets, net 26,899 28,101
Long-term tax assets 1,383 774
Other assets 1,559 1,737
Total assets $99,674 $106,685
Current liabilities
Short-term borrowings $885 $2,434
Accounts payable 1,709 1,610
Accrued compensation 1,712 1,611
Accrued income taxes 566 935
Deferred tax liabilities - 119
Other accrued expenses 2,185 2,464
Total current liabilities 7,057 9,173
Long-term debt 30,247 33,752
Long-term accrued compensation 1,759 1,535
Long-term accrued income taxes 2,903 2,476
Long-term deferred tax liabilities 3,729 4,700
Other long-term liabilities 1,916 1,819
Total liabilities 47,611 53,455
Shareholders’ equity
Ordinary shares - -
Retained earnings 53,931 54,414
Accumulated other comprehensive (loss) (1,868) (1,184)
Total shareholders’ equity 52,063 53,230
Total liabilities and shareholders’ equity $99,674 $106,685

Use the following assumptions to forecast the company’s balance sheet for FY2017.

Forecasted FY2017 net income $4,839

million

Forecasted FY2017 net sales $34,079

million

Accounts receivable 19.3%

of net sales

Inventories 12.0%

of net sales

Tax assets 2.4%

of net sales

Prepaid expenses and other current assets 4.3%

of net sales

Long-term tax assets 4.8%

of net sales

Other assets 5.4%

of net sales

Accounts payable 5.9%

of net sales

Accrued compensation 5.9%

of net sales

Accrued income taxes 2.0%

of net sales

Other accrued expenses 7.6%

of net sales

Long-term accrued income taxes 10.1%

of net sales

Long-term deferred tax liabilities 12.9%

of net sales

Other long-term liabilities 6.6%

of net sales

Investments No change
Goodwill No change
Long-term accrued compensation and retirement benefits No change
Ordinary shares No change
Accumulated other comprehensive (loss) No change
CAPEX 3.6%

of net sales

Depreciation expense 18.9%

of prior year PPE, net

Amortization expense in FY2016 $1,931

million

Current maturities of debt due in FY2017 $885

million

Current maturities of debt due in FY2018 $6,176

million

Dividend payout ratio 60.5%

Round your answers to the nearest whole number.

Do not use negative signs with any of your answers.

Medtronic plc
Forecasted Consolidated Balance Sheet
($ millions) EST. 2017
Current assets
Cash and cash equivalents $Answer
Investments Answer
Accounts receivable Answer
Inventories Answer
Tax assets Answer
Prepaid expenses and other current assets Answer
Total current assets Answer
Property, plant, and equipment, net Answer
Goodwill Answer
Other intangible assets, net Answer
Long-term tax assets Answer
Other assets Answer
Total assets $Answer
Current liabilities
Short-term borrowings $Answer
Accounts payable Answer
Accrued compensation Answer
Accrued income taxes Answer
Other accrued expenses Answer
Total current liabilities Answer
Long-term debt Answer
Long-term accrued compensation Answer
Long-term accrued income taxes Answer
Long-term deferred tax liabilities Answer
Other long-term liabilities Answer
Total liabilities Answer
Shareholders’ equity
Ordinary shares -
Retained earnings Answer
Accumulated other comprehensive (loss) Answer
Total shareholders’ equity Answer
Total liabilities and shareholders’ equity $Answer

Solutions

Expert Solution


Related Solutions

Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended...
Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016. Medtronic plc Consolidated Balance Sheets ($ millions) Apr. 29, 2016 Apr. 24, 2015 Current assets Cash and cash equivalents $2,768 $4,843 Investments 9,758 14,637 Accounts receivable 5,562 5,112 Inventories 3,473 3,463 Tax assets 697 1,335 Prepaid expenses and other current assets 1,234 1,454 Total current assets 23,492 30,844 Property, plant, and equipment, net 4,841 4,699 Goodwill 41,500 40,530 Other intangible assets,...
Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended...
Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016. Medtronic plc Consolidated Balance Sheets ($ millions) Apr. 29, 2016 Apr. 24, 2015 Current assets Cash and cash equivalents $2,988 $4,843 Investments 9,758 14,637 Accounts receivable 5,562 5,112 Inventories 3,473 3,463 Tax assets 697 1,335 Prepaid expenses and other current assets 1,234 1,454 Total current assets 23,712 30,844 Property, plant, and equipment, net 4,841 4,699 Goodwill 41,500 40,530 Other intangible assets,...
Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended...
Forecast the Balance Sheet Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016. Medtronic plc Consolidated Balance Sheets ($ millions) Apr. 29, 2016 Apr. 24, 2015 Current assets Cash and cash equivalents $3,221 $4,843 Investments 9,758 14,637 Accounts receivable 5,562 5,112 Inventories 3,473 3,463 Tax assets 697 1,335 Prepaid expenses and other current assets 1,234 1,454 Total current assets 23,945 30,844 Property, plant, and equipment, net 4,841 4,699 Goodwill 41,500 40,530 Other intangible assets,...
Forecast an Income Statement Following is the income statement for Medtronic PLC for the year ended...
Forecast an Income Statement Following is the income statement for Medtronic PLC for the year ended April 29, 2016. Consolidated Statements of Income Apr. 29, 2016 Apr. 24, 2015 Apr. 25, 2014 Net sales $29,944 $20,261 $17,005 Costs and expenses Cost of products sold 9,283 6,309 4,333 Research and development expense 2,224 1,640 1,477 Selling, general, and administrative expense 9,469 6,904 5,847 Special charges (gains), net 70 (38) 40 Restructuring charges, net 290 237 78 Certain litigation charges, net 26...
Refine Assumptions for PPE Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated...
Refine Assumptions for PPE Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,499 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,957 Interest expense, net 955 Income...
Forecast the Statement of Cash Flows Refer to the Medtronic PLC financial statement below. Use the...
Forecast the Statement of Cash Flows Refer to the Medtronic PLC financial statement below. Use the information to forecast Medtronic's FY2017 statement of cash flows. Medtronic plc Consolidated Statements of Income 12 Months Ended ($ millions) 2017 EST. Apr. 29, 2016 Net sales $35,864 $28,833 Costs and expenses Cost of products sold 11,151 9,142 Research and development expense 2,709 2,224 Selling, general, and administrative expense 11,538 9,469 Special charges (gains), net - 70 Restructuring charges, net 218 290 Certain litigation...
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC....
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,610 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 6,068 Interest expense,...
The following are some items of the balance sheet for Hofa, Inc., for the year ended...
The following are some items of the balance sheet for Hofa, Inc., for the year ended December 31, 2019. Prepare a balance sheet for December 31, 2019. If the company is to announce 10% stock dividends, who do think this will impact the balance sheet? Finished Goods $  8,532 Current Maturities of Long-Term Debt 1,197 Accumulated Depreciation 8,957 Accounts Receivable 25,101 Sales Revenue 127,260 Treasury Stock 251 Prepaid Expenses 2,199 Deferred Taxes (long-term liability) 8,237 Interest Expense 2,410 Allowance for Doubtful...
From the following trial balance of Iran bank, prepare the balance sheet for the year ended...
From the following trial balance of Iran bank, prepare the balance sheet for the year ended 31/12/2019. Particulars OMR OMR Share capital cr 4,000 Money at call and short notice   dr1,600 Reserve fund   cr 1,400 Cash in hand      dr 1,300 Deposits    cr 5,000 Cash at bank   dr1,900 Borrowing from NBO   cr 1,000 Investments in government securities dr 1,800 Secured loans dr 3,000 Term loan dr 1,000 Plant & Machinery less depreciation dr 1,160 Furniture less depreciation dr 240 Rent dr...
Medtronic plc Consolidated Statements of Income 12 Months Ended ($ millions) 2017 EST. Apr. 29, 2016...
Medtronic plc Consolidated Statements of Income 12 Months Ended ($ millions) 2017 EST. Apr. 29, 2016 Net sales $35,531 $28,833 Costs and expenses Cost of products sold 11,151 9,142 Research and development expense 2,709 2,224 Selling, general, and administrative expense 11,538 9,469 Special charges (gains), net - 70 Restructuring charges, net 218 290 Certain litigation charges, net - 26 Acquisition-related items 352 283 Amortization of intangible assets 1,931 1,931 Other expense, net 107 107 Operating profit 7,525 5,291 Interest expense,...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT